Log in to your Inderes Free account to see all free content on this page.
Camurus
566.00 SEK
+4.91 %
Less than 1K followers
CAMX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Camurus
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 479.6 | 553.1 | 1,867.6 | 558.3 | 675.5 | 567.1 | 464.5 | 2,265.4 |
| EBITDA | 141.8 | 166.1 | 469.2 | 238.9 | 292.1 | 230.2 | 119.4 | 880.6 |
| EBIT | 141.8 | 166.1 | 469.2 | 238.9 | 292.1 | 230.2 | 112.8 | 873.9 |
| EBIT-% | 29.6 % | 30.0 % | 25.1 % | 42.8 % | 43.2 % | 40.6 % | 24.3 % | 38.6 % |
| Profit before taxes | 165.3 | 186.2 | 552.5 | 254.0 | 307.0 | 245.3 | 126.8 | 933.1 |
| Net income | 129.4 | 147.0 | 428.4 | 197.3 | 244.8 | 192.6 | 100.9 | 735.6 |
Login required
This content is only available for logged in users